Cargando…
Concerning the article by Louveau et al “Clinical value of early detection of circulating tumour DNA BRAFV600mut in patients with metastatic melanoma treated with a BRAF inhibitor”
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
ESMO Open
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5519790/ https://www.ncbi.nlm.nih.gov/pubmed/28766586 http://dx.doi.org/10.1136/esmoopen-2017-000207 |
| _version_ | 1783251695031025664 |
|---|---|
| author | Robert, Caroline |
| author_facet | Robert, Caroline |
| author_sort | Robert, Caroline |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-5519790 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2017 |
| publisher | ESMO Open |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-55197902017-07-31 Concerning the article by Louveau et al “Clinical value of early detection of circulating tumour DNA BRAFV600mut in patients with metastatic melanoma treated with a BRAF inhibitor” Robert, Caroline ESMO Open Editorial ESMO Open 2017-07-19 /pmc/articles/PMC5519790/ /pubmed/28766586 http://dx.doi.org/10.1136/esmoopen-2017-000207 Text en © European Society for Medical Oncology (unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted. This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| spellingShingle | Editorial Robert, Caroline Concerning the article by Louveau et al “Clinical value of early detection of circulating tumour DNA BRAFV600mut in patients with metastatic melanoma treated with a BRAF inhibitor” |
| title | Concerning the article by Louveau et al “Clinical value of early detection of circulating tumour DNA BRAFV600mut in patients with metastatic melanoma treated with a BRAF inhibitor” |
| title_full | Concerning the article by Louveau et al “Clinical value of early detection of circulating tumour DNA BRAFV600mut in patients with metastatic melanoma treated with a BRAF inhibitor” |
| title_fullStr | Concerning the article by Louveau et al “Clinical value of early detection of circulating tumour DNA BRAFV600mut in patients with metastatic melanoma treated with a BRAF inhibitor” |
| title_full_unstemmed | Concerning the article by Louveau et al “Clinical value of early detection of circulating tumour DNA BRAFV600mut in patients with metastatic melanoma treated with a BRAF inhibitor” |
| title_short | Concerning the article by Louveau et al “Clinical value of early detection of circulating tumour DNA BRAFV600mut in patients with metastatic melanoma treated with a BRAF inhibitor” |
| title_sort | concerning the article by louveau et al “clinical value of early detection of circulating tumour dna brafv600mut in patients with metastatic melanoma treated with a braf inhibitor” |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5519790/ https://www.ncbi.nlm.nih.gov/pubmed/28766586 http://dx.doi.org/10.1136/esmoopen-2017-000207 |
| work_keys_str_mv | AT robertcaroline concerningthearticlebylouveauetalclinicalvalueofearlydetectionofcirculatingtumourdnabrafv600mutinpatientswithmetastaticmelanomatreatedwithabrafinhibitor |